Nyxoah (NYXH) Net Income towards Common Stockholders (2025 - 2026)

Nyxoah's quarterly Net Income towards Common Stockholders came in at $19.0 million in Q1 2026, down 19.19% year-on-year from $23.5 million in Q1 2025, and down 19.19% quarter-over-quarter from $23.5 million in Q1 2025.

Nyxoah has reported Net Income towards Common Stockholders for 2 years, with the latest figure at $19.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 19.19% year-over-year to $19.0 million; the trailing twelve-month figure through Mar 2026 stood at $42.6 million (up 80.81% YoY), and the FY2025 full-year result was -$104.9 million, down 65.66% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $19.0 million, down from $23.5 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $23.5 million in Q1 2025, with the low at $19.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -274.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 398.73 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 135.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 13.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 130.80 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 112.77 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 72.77 Mn
10 Nyxoah 1,248.49 1,248.49 4.26 Mn 19.03 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.03 Mn
Mar 31, 2025 23.55 Mn